Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by Roswell Park Memorial Institute
- 1 June 1984
- Vol. 23 (6), 54-63
- https://doi.org/10.1016/s0090-4295(84)80100-4
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Stable versus partial response in advanced prostate cancerThe Prostate, 1984
- The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostateJournal of Surgical Oncology, 1983
- Estramustine phosphate with multiple cytotoxic agents in treatment of advanced prostatic cancerUrology, 1981
- Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the ProstateJournal of Urology, 1981
- The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancerCancer, 1980
- Treatment of Advanced Carcinoma of the Prostate with Estramustine PhosphateBritish Journal of Urology, 1977
- Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)Scandinavian Journal of Urology and Nephrology, 1977
- Treatment of Rapidly Progressing Prostatic Carcinoma with EstracytJournal of Urology, 1972
- Estracyt® in Advanced Prostatic Carcinoma: Case ReportScandinavian Journal of Urology and Nephrology, 1972
- Treatment of Advanced Prostatic Carcinoma with Estracyt: A Preliminary ReportScandinavian Journal of Urology and Nephrology, 1971